We are proud to announce that molecular-diagnostics pioneer QIAGEN is again a key partner in DxPx, which hosts two annual dedicated partnering conferences; one in the US in the summer and one in Europe in the fall. QIAGEN’s corporate business development team will be available to meet start-ups and industry peers for the entire duration of DxPx US.
“QIAGEN is always on the lookout for partners who share our vision of getting innovative products onto the markets of the world as quickly as possible,” said Sebastian Swienty, Senior Director Corporate Business Development Licensing at QIAGEN.
“The cooperation of AACC as largest diagnostics trade fair in the world with the DxPx is a clear win for us. We look forward to participating again as partner and juror for the 42plus1 Pitch Award.”
Senior Director, Corporate Business Development Licensing
Heading to Anaheim, California – July 25th – 27th, 2023 – for 3 days full of networking opportunities, in the heart of the AACC Clinical Lab Expo. Join DxPx US to discuss M&A, licensing, and financing opportunities, meet old acquaintances and make new international contacts.
Meet investors and industry partners who share your love for Diagnostics, Digital Health, Precision Medicine & Life Science Tools.
A great way to present your company to investors and partners.
We offer a limited number of exhibition booths directly in the partnering area and main reception area.